A founder of the field of synthetic biology is selling data from his own DNA as a nonfungible token, or NFT, through Nebula Genomics, a personal genome company he cofounded.

Sykes sequenced famous ancient remains, such as Ötzi and Cheddar Man, and was one of the first researchers to use mitochondrial DNA to trace genetic lineages.

A selective advantage may have led the modern human Y chromosome to sweep through the Neanderthal population after it was introduced via interbreeding more than 100,000 years ago.

Working with a virus that infects bacteria, the Stanford University biochemist and developmental biologist helped to develop a way to stitch DNA together, a discovery that gave rise to genetic engineering.

In addition to his work on widely-used techniques, the researcher was known for engineering crop plants.

Sequences from dozens of ancient remains from Siberia reveal the closest ancient relative of Native Americans found outside of North America.

When people prefer to go to bed is linked to hundreds of variations in their genes.

The PsychENCODE project delves into the DNA, RNA, and protein changes related to brain development and neuropsychiatric disorders, but researchers caution it’s just a first step toward treatment.

A small pilot study suggests the approach can identify effective treatments already approved for other cancers.

Combining data from the genetic testing techniques can guide patient care, scientists say.

The Vertebrate Genomes Project has released data on 14 vertebrate species, but the goal is to sequence all 66,000.

Luna DNA, Nebula Genomics, and other “bio-brokers” will allow customers to make money by granting access to their genetic and personal information for research purposes.

Scientists are searching for signatures of mammals within the blood meals of the invertebrates.

See the American Museum of Natural History curator Mark Sidall explain his fascination with leeches, which he and other scientists are using to infer biodiversity in some far-flung places.

Clinical analyses of patients’ gene sequences are helping to provide answers where none were available before.